-Microscopy (MICRO) Shared Resource The Microscopy Shared Resource (MICRO) is a CCSG basic shared resource that combines the expertise and equipment from three different imaging modalities: light microscopy, intravital microscopy and electron microscopy. This combination gives LCCC members access to outstanding imaging capabilities. Visualization of the process of oncogenesis from tumors in whole organs, to cancer cells invading normal tissues, to transformed cells growing in culture and finally visualization of the macromolecules which lie at the heart of transformation provides a critical means of understanding, manipulating, and ultimately combating cancer. Having a broad range of imaging tools immediately available to the cancer research community at UNC within the LCCC is essential if the diverse research of the many cutting edge studies are to progress rapidly toward their goals in cancer research. This requires specialized techniques spanning a range of visualization that encompasses light and electron microscopy and dimensions of millimeters to nanometers. To provide this technology to the LCCC members, three highly specialized laboratories work together and each has an excellent history of accomplishments. The three components of the LCCC Microscopy SR consist of: The Microscopy Services Laboratory (MSL) which stands as the main supplier of widefield, confocal, and live cell imaging plus image analysis and morphometry. The Intravital Imaging SR provides a unique set of microscopes and expertise for imaging cells, tissues and organs within a living animal. The Electron Microscopy SR provides specialized imaging techniques for macromolecular imaging that have been developed by the SR director and are used world wide. Taken together, these three SRs provide a powerful tool for our cancer researchers. Future directions include expansion of light microscopy into the realm of super-resolution imaging and establishment of new methods for tagging specific proteins such that they can be localized in cells by high resolution thin sectioning.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-44
Application #
9834849
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Valle, Carmina G; Queen, Tara L; Martin, Barbara A et al. (2018) Optimizing Tailored Communications for Health Risk Assessment: A Randomized Factorial Experiment of the Effects of Expectancy Priming, Autonomy Support, and Exemplification. J Med Internet Res 20:e63
Sun, Junjiang; Shao, Wenwei; Chen, Xiaojing et al. (2018) An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs. Mol Ther Methods Clin Dev 10:257-267
Wilczewski, Caralynn M; Hepperla, Austin J; Shimbo, Takashi et al. (2018) CHD4 and the NuRD complex directly control cardiac sarcomere formation. Proc Natl Acad Sci U S A 115:6727-6732
Waters, Andrew M; Der, Channing J (2018) KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer. Cold Spring Harb Perspect Med 8:
Cai, Ling; Tsai, Yi-Hsuan; Wang, Ping et al. (2018) ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer. Mol Cell 72:341-354.e6
Moschos, Stergios J; Sullivan, Ryan J; Hwu, Wen-Jen et al. (2018) Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors. JCI Insight 3:
Brosnan, Evelyn M; Anders, Carey K (2018) Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies. Ann Transl Med 6:163
Zhang, Jing; Wu, Tao; Simon, Jeremy et al. (2018) VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science 361:290-295
Zhang, Cun-Jin; Wang, Chenhui; Jiang, Meiling et al. (2018) Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun 9:2745
Anderson, Chelsea; Engel, Stephanie M; Anders, Carey K et al. (2018) Live birth outcomes after adolescent and young adult breast cancer. Int J Cancer 142:1994-2002

Showing the most recent 10 out of 1525 publications